期刊文献+

用硫酸氢氯吡格雷对老年冠心病患者进行治疗的效果探析 被引量:1

下载PDF
导出
摘要 目的:探究用硫酸氢氯吡格雷对老年冠心病患者进行治疗的临床效果。方法:将2016年1月至2017年6月期间宜兴市和桥医院接诊的106例老年冠心病患者作为研究对象。应用随机数表法将其分成常规组和探究组。为常规组患者应用阿司匹林进行治疗,为探究组患者应用硫酸氢氯吡格雷进行治疗。然后比较两组患者的临床疗效和各项凝血功能指标的变化情况。结果:探究组患者治疗的总有效率(94.3%)高于常规组患者治疗的总有效率(77.4%),差异有统计学意义(P<0.05)。治疗后,探究组患者的APTT长于常规组患者,其PA低于常规组患者(P<0.05)。结论:用硫酸氢氯吡格雷对老年冠心病患者进行治疗的临床效果确切。
作者 邵军忠
出处 《当代医药论丛》 2018年第4期65-67,共3页
  • 相关文献

二级参考文献41

  • 1Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) [J]. European heart journal, 2012,33 (13) : 1635-1701.
  • 2Ryden L,Grant PJ,Anker SD,et al. ESC Guidelines on diabetes,pre-diabetes and cardiovascular diseases devel- oped in collaboration with the EASD [J]. European heart journal, 2013,34(39) : 3035-3087.
  • 3Darlington A, Te!lo-Montoliu A, Rollini F, et al. Pharmac- odynamic effects of standard dose prasugrel versus high dose clopidogre! in non-diabetic obese patients with coronary artery disease [J]. Thromb Haemost, 2014,111 (2) : 258-265.
  • 4Angiolillo D J, Jakubowski JA, Ferreiro JL, et al. Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease [J]. Journal of the American College of Cardiology, 2014, 64 (10): 1005-1014.
  • 5Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease [J]. European heart journal, 2013,34 (38) : 2949 - 3003.
  • 6Roe MT,Armstrong PW,Fox KAA,et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascul- arization [J]. New England Journal of Medicine, 2012,367 (14) : 1297-1309.
  • 7Thukkani AK,Agrawal K,Prince L,et al. Long-term outcomes in patients with diabetes mellitus related to prolonging clopidogrel more than 12 months after coronary stenting [J]. Journal of the American College of Cardiology,2015,66 (10) : 1091-1101.
  • 8Andersson C,Lyngbaek S,Nguyen CD,et al. Association of clopidogrel treatment with risk of mortality and cardi- ovascular events following myocardial infarction in patients with and without diabetes [J]. JAMA,2012,308(9):882- 889.
  • 9Siller-Matula JM, Delle -Karth G, Christ G,et al. Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-re- sponsiveness to clopidogrel or aspirin [J]. International journal of cardiology, 2013,167 (2) : 430-435.
  • 10刘莹.冠心病患者双联抗血小板治疗并发消化道出血防治的研究[C].//第七届北京五洲心血管病研讨会论文集.2013:619-621.

共引文献139

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部